Growth strategy for Greek pharma industry

19 May 2014

An action plan to unlock the huge potential of the pharmaceutical industry in Greece and underscore its role as a key driver of growth in the Greek economy was the outcome of an event organised by the Greek research-based pharma trade group SFEE, in the context of the Greek Presidency of the European Union and the eHealth Forum 2014, to launch the study “A Growth Strategy for the Pharmaceutical Industry,” prepared by the Foundation of Economic and Industrial Research (FEIR/IOBE).

At a time when an exit of the Greek economy from a six-year recession is being sought, the pharmaceutical industry, with innovation at the core of its activity, offers a real way out.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight



More Features in Pharmaceutical